Young at heart. An update on cardiac regeneration

Minerva Medica

Volumn 101, Issue 4, 2010, Pages 255-269

  Smits, A M ^a   Ramkisoensing, A A ^a   Atsma, D E ^a   Goumans, M J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cardiovascular diseases; Myocardial infarction; Regeneration

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; PROTEIN ISL 1; STEM CELL ANTIGEN 1; STEM CELL FACTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; CARDIOVASCULAR DISEASE; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELL THERAPY; HEART CONTRACTION; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CELL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; PROTEIN EXPRESSION; REGENERATION; REVIEW;

ANTIGENS, LY; HEART FAILURE; HOMEODOMAIN PROTEINS; HUMANS; MEMBRANE PROTEINS; MESENCHYMAL STEM CELLS; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; PROTO-ONCOGENE PROTEINS C-KIT; REGENERATION; STEM CELLS;

EID: 79251528236     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (96)

1. Reinecke H, Zhang M, Bartosek T, Murry CE. Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation 1999;100:193-202.
2. Soonpaa MH, Koh GY, Klug MG, Field LJ. Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science 1994;264:98-101.
3. Menasche P. Skeletal myoblasts as a therapeutic agent. Prog Cardiovasc Dis 2007;50:7-17.
4. Hagege AA, Carrion C, Menasche P, Vilquin JT, Duboc D, Marolleau JP et al. Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 2003;361:491-2. (Pubitemid 36173717)
5. Leobon B, Garcin I, Menasche P, Vilquin JT, Audinat E, Charpak S. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci U S A 2003;100:7808-11. (Pubitemid 36760051)
6. Guo C, Haider HK, Shim WS, Tan RS, Ye L, Jiang S et al. Myoblast-based cardiac repair: xenomyoblast versus allomyoblast transplantation. J Thorac Cardiovasc Surg 2007;134:1332-9.
7. Menasche P, Hagege AA, Vilquin JT, Desnos M, Abergel E, Pouzet B et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003;41:1078-83.
8. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701-5.
9. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004;428:668-73.
10. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004;428:664-8. (Pubitemid 38524810)
11. Lipinski MJ, Biondi-Zoccai GG, Abbate A, Khianey R, Sheiban I, Bartunek J et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol 2007;50:1761-7.
12. Poss KD, Wilson LG, Keating MT. Heart regeneration in zebrafish. Science 2002;298:2188-90.
13. Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, Bussani R et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001;344:1750-7.
14. Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabe-Heider F, Walsh S et al. Evidence for cardiomyocyte renewal in humans. Science 2009;324:98-102.
15. Hsieh PC, Segers VF, Davis ME, MacGillivray C, Gannon J, Molkentin JD et al. Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat Med 2007;13:970-4.
16. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003;114:763-76.
17. Messina E, De Angelis L, Frati G, Morrone S, Chimenti S, Fiordaliso F et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 2004,95.911-21.
18. Smith RR, Barile L, Cho HC, Leppo MK, Hare JM, Messina E et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 2007;115:896-908.
19. Laugwitz KL, Moretti A, Lam J, Gruber P, Chen Y, Woodard S et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 2005;433:647-53.
20. Bearzi C, Rota M, Hosoda T, Tillmanns J, Nascimbene A, De Angelis A et al. Human cardiac stem cells. Proc Natl Acad Sci U S A 2007;104:14068-73.
21. Goumans MJ, de Boer TP, Smits AM, van Laake LW, van Vliet P, Metz CH et al. TGF-beta1 induces efficient differentiation of human cardiomyocyte progenitor cells into functional cardiomyocytes in vitro. Stem Cell Res 2007;1:138-49.
22. Oh H, Bradfute SB, Gallardo TD, Nakamura T, Gaussin V, Mishina Y et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A 2003;100:12313-8.
23. Davis DR, Zhang Y, Smith RR, Cheng K, Terrovitis J, Malliaras K et al. Validation of the cardiosphere method to culture cardiac progenitor cells from myocardial tissue. PLoS One 2009;4:e7195.
24. Shenje LT, Field LJ, Pritchard CA, Guerin CJ, Rubart M, Soonpaa MH et al. Lineage tracing of cardiac explant derived cells. PLoS One 2008;3:e1929.
25. Andersen DC, Andersen P, Schneider M, Jensen HB, Sheikh SP. Murine "cardiospheres" are not a source of stem cells with cardiomyogenic potential. Stem Cells 2009;27:1571-81.
26. Cai CL, Liang X, Shi Y, Chu PH, Pfaff SL, Chen J et al. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell 2003;5:877-89.
27. Moretti A, Lam J, Evans SM, Laugwitz KL. Biology of Isl1+ cardiac progenitor cells in development and disease. Cell Mol Life Sci 2007;64:674-82.
28. Bu L, Jiang X, Martin-Puig S, Caron L, Zhu S, Shao Y et al. Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature 2009;460:113-7.
29. Boni A, Urbanek K, Nascimbene A, Hosoda T, Zheng H, Delucchi F et al. Notch1 regulates the fate of cardiac progenitor cells. Proc Natl Acad Sci U S A 2008;105:15529-34.
30. Wu SM, Fujiwara Y, Cibulsky SM, Clapham DE, Lien CL, Schultheiss TM et al. Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell 2006;127:1137-50. (Pubitemid 44914005)
31. Tallini YN, Greene KS, Craven M, Spealman A, Breitbach M, Smith J et al. c-kit expression identifies cardiovascular precursors in the neonatal heart. Proc Natl Acad Sci U S A 2009;106:1808-13.
32. Zaruba MM, Soonpaa M, Reuter S, Field LJ. Cardiomyogenic potential of C-kit(+)-expressing cells derived from neonatal and adult mouse hearts. Circulation 2010;121:1992-2000.
33. Matsuura K, Nagai T, Nishigaki N, Oyama T, Nishi J, Wada H et al. Adult cardiac Sea-1-positive cells differentiate into beating cardiomyocytes. J Biol Chem 2004;279:11384-91.
34. Wang X, Hu Q, Nakamura Y, Lee J, Zhang G, From AH et al. The role of the sca-1+/CD31- cardiac progenitor cell population in postinfarction left ventricular remodeling. Stem Cells 2006;24:1779-88.
35. van Vliet P, Roccio M, Smits AM, van Oorschot AA, Metz CH, van Veen TA et al. Progenitor cells isolated from the human heart: a potential cell source for regenerative therapy. Neth Heart J 2008;16:163-9.
36. Smits AM, van Vliet P, Metz CH, Korfage T, Sluijter JP, Doevendans PA et al. Human cardiomyocyte progenitor cells differentiate into functional mature cardiomycoytes: an in vitro model for studying human cardiac physiology and pathophysiology. Nat Protoc 2009;4:232-43.
37. Smits AM, van Laake LW, denOuden K, Schreurs C, Szuhai K, van Echteld CJ et al. Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium. Cardiovasc Res 2009;
38. van Vliet P., Smits AM, de Boer TP, Korfage TH, Metz CH, Roccio M et al. Fetal and adult cardiomyocyte progenitor cells have different developmental potential. J Cell Mol Med 2010;
39. Bondue A, Lapouge G, Paulissen C, Semeraro C, Iacovino M, Kyba M et al. Mesp1 acts as a master regulator of multipotent cardiovascular progenitor specification. Cell Stem Cell 2008;3:69-84.
40. Kattman SJ, Huber TL, Keller GM. Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev Cell 2006;11:723-32.
41. Moretti A, Caron L, Nakano A, Lam JT, Bernshausen A, Chen Y et al. Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 2006;127:1151-65.
42. Fazel S, Cimini M, Chen L, Li S, Angoulvant D, Fedak P et al. Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest 2006;116:1865-77.
43. Mouquet F, Pfister O, Jain M, Oikonomopoulos A, Ngoy S, Summer R et al. Restoration of cardiac progenitor cells after myocardial infarction by self-proliferation and selective homing of bone marrow-derived stem cells. Orc Res 2005;97:1090-2. (Pubitemid 43755201)
44. Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 1968;6:230-47.
45. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-7.
46. Battula VL, Treml S, Bareiss PM, Gieseke F, Roelofs H, de Zwart P et al. Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1. Haematologica 2009;94:173-84.
47. Buhring HJ, Battula VL, Treml S, Schewe B, Kanz L, Vogel W. Novel markers for the prospective isolation of human MSC. Ann N Y Acad Sci 2007;1106:262-71.
48. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008;3:301-13.
49. Miyahara Y, Nagaya N, Kataoka M, Yanagawa B, Tanaka K, Hao H et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 2006;12:459-65.
50. Covas DT, Panepucci RA, Fontes AM, Suva WA, Jr., Orellana MD, Freitas MC et al. Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts. Exp Hematol 2008;36:642-54.
51. da Silva ML, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006;119:2204-13.
52. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006;24:1294-301.
53. Secco M, Moreira YB, Zucconi E, Vieira NM, Jazedje T, Muotri AR et al. Gene expression profile of mesenchymal stem cells from paired umbilical cord units: cord is different from blood. Stem Cell Rev 2009;5:387-401.
54. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002;13:4279-95.
55. Bunnell BA, Flaat M, Gagliardi C, Patel B, Ripoll C. Adipose-derived stem cells: isolation, expansion and differentiation. Methods 2008;45:115-20. (Pubitemid 351885360)
56. Krampera M, Sartoris S, Liotta F, Pasini A, Angeli R, Cosmi L et al. Immune regulation by mesenchymal stem cells derived from adult spleen and thymus. Stem Cells Dev 2007;16:797-810.
57. Trubiani O, Orsini G, Caputi S, Piatelli A. Adult mesenchymal stem cells in dental research: a new approach for tissue engineering. Int J Immunopathol Pharmacol 2006;19:451-60.
58. Roufosse CA, Direkze NC, Otto WR, Wright NA. Circulating mesenchymal stem cells. Int J Biochem Cell Biol 2004;36:585-97.
59. Meliga E, Strem BM, Duckers HJ, Serruys PW. Adipose-derived cells. Cell Transplant 2007;16:963-70.
60. Heiss C, Keymel S, Niesler U, Ziemann J, Kelm M, Kalka C. Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol 2005;45:1441-8.
61. Vasa M, Fichtischerer S, Aicher A, Adler K, Urbich C, Martin H et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001;89:E1-E7.
62. Jo CH, Kim OS, Park EY, Kim BJ, Lee JH, Kang SB et al. Fetal mesenchymal stem cells derived from human umbilical cord sustain primitive characteristics during extensive expansion. Cell Tissue Res 2008;334:423-33.
63. Nishiyama N, Miyoshi S, Hida N, Uyama T, Okamoto K, Ikegami Y et al. The significant cardiomyogenic potential of human umbilical cord blood-derived mesenchymal stem cells in vitro. Stem Cells 2007;25:2017-24.
64. Roubelakis MG, Pappa KI, Bitsika V, Zagoura D, Vlahou A, Papadaki HA et al. Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells. Stem Cells Dev 2007;16:931-52.
65. Tsuji H, Miyoshi S, Ikegami Y, Hida N, Asada H, Togashi I et al. Xenografted human amniotic membrane-derived mesenchymal stem cells are immunologically tolerated and transdifferentiated into cardiomyocytes. Circ Res 2010;106:1613-23.
66. Guillot PV, Gotherstrom C, Chan J, Kurata H, Fisk NM. Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. Stem Cells 2007;25:646-54.
67. Roobrouck VD, Ulloa-Montoya F, Verfaillie CM. Self-renewal and differentiation capacity of young and aged stem cells. Exp Cell Res 2008;314:1937-44.
68. Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 2009;54:2277-86.
69. Liechty KW, MacKenzie TC, Shaaban AF, Radu A, Moseley AM, Deans R et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 2000;6:1282-6.
70. Saito T, Kuang JQ, Bittira B, Al-Khaldi A, Chiu RC. Xenotransplant cardiac chimera: immune tolerance of adult stem cells. Ann Thorac Surg 2002;74:19-24. (Pubitemid 34741999)
71. Barberi T, Willis LM, Socci ND, Studer L. Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS Med 2005;2:e161.
72. Trivedi P , Hematti P. Simultaneous generation of CD34+ primitive hematopoietic cells and CD73+ mesenchymal stem cells from human embryonic stem cells cocultured with murine OP9 stromal cells. Exp Hematol 2007;35:146-54.
73. Karlsson C, Emanuelsson K, Wessberg F, Kajic K, Axell MZ, Eriksson PS et al. Human embryonic stem cell-derived mesenchymal progenitors-Potential in regenerative medicine. Stem Cell Res 2009;
74. Hwang NS, Varghese S, Lee HJ, Zhang Z, Ye Z, Bae J et al. In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells. Proc Natl Acad Sci U S A 2008;105:20641-6.
75. MacKenzie TC , Flake AW. Multilineage differentiation of human MSC after in utero transplantation. Cytotherapy 2001;3:403-5.
76. Warejcka DJ, Harvey R, Taylor BJ, Young HE, Lucas PA. A population of cells isolated from rat heart capable of differentiating into several mesodermal phenotypes. J Surg Res 1996;62:233-42. (Pubitemid 26142417)
77. Nygren JM, Jovinge S, Breitbach M, Sawen P, Roll W, Hescheler J et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 2004;10:494-501.
78. Alvarez-Dolado M. Cell fusion: biological perspectives and potential for regenerative medicine. Front Biosci 2007;12:1-12.
79. Rose RA, Jiang H, Wang X, Helke S, Tsoporis JN, Gong N et al. Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro. Stem Cells 2008;26:2884-92.
80. Pijnappels DA, Schalij MJ, van Tuyn J, Ypey DL, de Vries AA, van der Wall EE et al. Progressive increase in conduction velocity across human mesenchymal stem cells is mediated by enhanced electrical coupling. Cardiovasc Res 2006;72:282-91.
81. Pijnappels DA, Schalij MJ, Ramkisoensing AA, van Tuyn J, de Vries AA, van der Laarse A et al. Forced alignment of mesenchymal stem cells undergoing cardiomyogenic differentiation affects functional integration with cardiomyocyte cultures. Circ Res 2008;103:167-76.
82. Grauss RW, Winter EM, van Tuyn J., Pijnappels DA, Steijn RV, Hogers B et al. Mesenchymal stem cells from ischemic heart disease patients improve left ventricular function after acute myocardial infarction. Am J Physiol Heart Circ Physiol 2007;293:H2438-H2447.
83. Jiang S, Kh HH, Ahmed RP, Idris NM, Salim A, Ashraf M. Transcriptional profiling of young and old mesenchymal stem cells in response to oxygen deprivation and reparability of the infarcted myocardium. J Mol Cell Cardiol 2008;44:582-96.
84. Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, Fuchs S et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 2004;94:678-85. (Pubitemid 38387752)
85. Chen MY, Lie PC, Li ZL, Wei X. Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells. Exp Hematol 2009;37:629-40.
86. Li TS, Kubo M, Ueda K, Murakami M, Mikamo A, Hamano K. Impaired angiogenic potency of bone marrow cells from patients with advanced age, anemia, and renal failure. J Thorac Cardiovasc Surg 2010;139:459-65.
87. Bellantuono I , Keith WN. Stem cell ageing: does it happen and can we intervene? Expert Rev Mol Med 2007;9:1-20.
88. Chambers SM , Goodell MA. Hematopoietic stem cell aging: wrinkles in stem cell potential. Stem Cell Rev 2007;3:201-11.
89. Taylor CJ, Bolton EM, Pocock S, Sharpies LD, Pedersen RA, Bradley JA. Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching. Lancet 2005;366:2019-25.
90. Csete M. Oxygen in the cultivation of stem cells. Ann N Y Acad Sci 2005;1049:1-8.
91. Shimizu T, Sekine H, Yamato M, Okano T. Cell sheet-based myocardial tissue engineering: new hope for damaged heart rescue. Curr Pharm Des 2009;15:2807-14.
92. Zimmermann WH, Melnychenko I, Wasmeier G, Didie M, Naito H, Nixdorff U et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 2006;12:452-8.
93. Zakharova L, Mastroeni D, Mutlu N, Molina M, Goldman S, Diethrich E et al. Transplantation of cardiac progenitor cell sheet onto infarcted heart promotes cardiogenesis and improves function. Cardiovasc Res 2010;87:40-9.
94. Ziebart T, Yoon CH, Trepels T, Wietelmann A, Braun T, Kiessling F et al. Sustained persistence of transplanted proangiogenic cells contributes to neovascularization and cardiac function after ischemia. Circ Res 2008;103:1327-34.
95. Timmers L, Lim SK, Arslan F, Armstrong JS, Hoefer IE, Doevendans PA et al. Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. Stem Cell Research 2007;1:129-37. (Pubitemid 351736003)
96. Lai RC, Arslan F, Lee MM, Sze NS, Choo A, Chen TS et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 2010;4:214-22.